Greece Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Greece Pharmaceuticals and Healthcare Report Q3 2013 Jun 26th 2013, 00:00 BMI View: The Greek pharmaceutical market will continue to be characterised by mandated price reductions, state intervention in pharmaceutical trade and regressive revenue taxes. Although there have been positive developments towards the payment of hospital debts, the Greek state will need to cut healthcare costs and drive efficiency to prevent debt from building up again. Moreover, the Greek government will continue to shift the burden of healthcare spending onto its citizens, requiring co-payments for expensive drugs and payments for outpatient visits. Headline Expenditure Projections ? Pharmaceuticals: EUR5.99bn (US$7.61bn) in 2012 to EUR5.62bn (US$7.53bn) in 2013; -6.2% in local currency terms … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=104085. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/greece-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions